ons-5010/lytenava
Generic: bevacizumab·Code: ONS-5010
ons-5010/lytenava: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Outlook Therapeutics, Inc. (OTLK) | BLA Filed |
Get deeper analysis on ons-5010/lytenava
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis